The prescribing of Chinese herbal products in Taiwan: A cross-sectional analysis of the national health insurance reimbursement database

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 6, 2008, Pages 609-619

  Hsieh, Shu Ching ^a,b   Lai, Jung Nien ^c,d   Lee, Chuan Fang ^e,f   Hu, Fu Chang ^g   Tseng, Wei Lum ^d   Wang, Jung Der ^b,g  

^a Center for Drug Evaluation   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI CITY HOSPITAL   (Taiwan)

^e TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^f NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Chinese herbal products; Cross sectional data analysis; Data mining; Prescription patterns

Indexed keywords

ANGELICA EXTRACT; BAN XIA XIE XIN TANG; CARTHAMUS EXTRACT; CHINESE DRUG; CHUAN QIONG CHA DIAO SAN; CYPERI EXTRACT; DANG GUI NIAN TONG TANG; DU HUO JI SHEN TANG; FRITILLARIAE EXTRACT; GLYCYRRHIZA URALENSIS EXTRACT; HERBACEOUS AGENT; HOUTTUYNIA CORDATA EXTRACT; ISATIS EXTRACT; JIA WEI XIAO YAO SAN; MA XING GAN SHI TANG; MYRRHA EXTRACT; PING WEI SAN; PLANT MEDICINAL PRODUCT; PLATYCODON GRANDIFLORUM EXTRACT; PREMAELLE; PUERARIA EXTRACT; SALVIA MILTIORRHIZA EXTRACT; SCUTELLARIAE RADIX; SHAO YAO GAN CAO TANG; SHIN YI CHING FEY TANG; SHU JING HUO XUE TANG; SUAN ZAO REN TANG; UNINDEXED DRUG; YAN HU SUO; YE JIAO TENG; YIN QIAO SAN;

ADOLESCENT; ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; BACKACHE; CHINESE MEDICINE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA BASE; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG UTILIZATION; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENSTRUATION DISORDER; NATIONAL HEALTH INSURANCE; OUTPATIENT; PRESCRIPTION; PRIORITY JOURNAL; REIMBURSEMENT; RESPIRATORY TRACT DISEASE; RHINOPHARYNGITIS; SLEEP DISORDER; TAIWAN; AGE; CHILD; CLINICAL PRACTICE; DRUG COMBINATION; FACTUAL DATABASE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; SEX DIFFERENCE; STATISTICS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PHARMACOEPIDEMIOLOGY; PHYSICIAN'S PRACTICE PATTERNS; SEX FACTORS; TAIWAN;

EID: 46349110645     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1611     Document Type: Article

References (38)

1. Chan MF, Mok E, Wong YS, et al. Attitudes of Hong Kong Chinese to traditional Chinese medicine and western medicine: survey and cluster analysis. Complement Ther Med 2003; 11: 103-109. DOI: 10.1016/ S0965-2299(03)00044-X
2. Chi C. Integrating traditional medicine into modern health care systems: examining the role of Chinese medicine in Taiwan. Soc Sci Med 1994; 39: 307-321.
3. Hong CD. Complementary and alternative medicine in Korea: current status and future prospects. J Altern Complement Med 2001; 7 (Suppl): S33-S40.
4. Lim MK, Sadarangani P, Chan HL, et al. Complementary and alternative medicine use in multiracial Singapore. Complement Ther Med 2005; 13: 16-24. DOI: 10.1016/j.ctim.2004.11.002
5. Yamashita H, Tsukayama H, Sugishita C. Popularity of complementary and alternative medicine in Japan: a telephone survey. Complement Ther Med 2002; 10: 84-93. DOI: 10.1054/ctim.2002.0519
6. Chan K. Chinese medicinal materials and their interface with western medical concepts. J Ethnopharmacol 2005; 96: 1-18. DOI: 10.1016/j.jep.2004.09.019
7. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280: 1569-1575.
8. World Health Organization. WHO Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems. World Health Organization: Geneva, 2004; http://www.who.int/medicinedocs/collect/ edmweb/index/assoc/s7148e/s7148e.pdf (accessed 09 December 2007).
9. Hsieh SC, Lai JN, Chen PC, et al. Development of active safety surveillance system for traditional Chinese medicine: an empirical study in treating climacteric women. Pharmacoepidemiol Drug Saf 2006; 15: 889-899. DOI:10.1002/pds. 1340
10. Lai JN, Hwang JS, Chen HJ, et al. Finished herbal product as an alternative treatment for menopausal symptoms in climacteric women. J Altern Complement Med 2005; 11: 1075-1084.
11. Lai JN, Chen HJ, Chen CC, et al. Duhuo jisheng tang for treating osteoarthritis of the knee: a prospective clinical observation. Chin Med 2007; 2: 4.
12. Bensoussan A, Myers SP. An analysis of patients using traditional Chinese medicine. Towards a Safer Choice: The Practice of Traditional Chinese Medicine in Australia. Southern Cross University: Victoria, 2003; 123-131.
13. Chuang CH, Hsieh WS, Guo YL, et al. Chinese herbal medicines used in pregnancy: a population-based survey in Taiwan. Pharmacoepidemiol Drug Saf 2007; 16: 464-468. 10.1002/pds.1332
14. Critchley LA, Chen DQ, Lee A, et al. A survey of Chinese herbal medicine intake amongst preoperative patients in Hong Kong. Anaesth Intensive Care 2005; 33: 506-513.
15. Ng TP, Tan CH, Kua EH. The use of Chinese herbal medicines and their correlates in Chinese older adults: the Singapore Chinese Longitudinal Aging Study. Age Ageing 2004; 33: 135-142. DOI: 10.1093/ ageing/afh016
16. Kung YY, Chen YC, Hwang SJ, et al. The prescriptions frequencies and patterns of Chinese herbal medicine for allergic rhinitis in Taiwan. Allergy 2006; 61: 1316-1318. DOI: 10.1111/ j.1398-9995.2006.01152.x
17. Chen LC, Wang BR, Chou YC, et al. Drug utilization pattern of Chinese herbal medicines in a general hospital in Taiwan. Pharmacoepidemiol Drug Saf 2005; 14: 651-657. DOI: 10.1002/ pds.1087
18. Chen FP, Chen TJ, Kung YY, et al. Use frequency of traditional Chinese medicine in Taiwan. BMC Health Serv Res 2007; 7: 26. DOI: 10.1186/1472-6963-7-26
19. Bureau of National Health Insurance. The National Health Insurance Statistics - detailed ambulatory care claims by global budget payment system. 2004, http://www.nhi.gov.tw/webdata/webdata.asp?menu= 1&menu_id=4&webdata_id=1399 (accesed 09 January 2007).
20. Bureau of National Health Insurance. Nation Health Insurance research database, http://www.nhri.org.tw/nhird/(accessed 01 January 2007).
21. Bureau of National Health Insurance. Instant statistical information-important statistical information- reimbursement transactions, http://www.nhi.gov.tw/webdata/webdata.asp?menu= 1&menu_id=4&webdata_id=805 (accessed 05 March 2007).
22. Bureau of National Health Insurance. List of reimbursed Chinese herbal products. http://www.nhi.gov.tw/webdata/webdata. asp?menu=&menu_id=26&webdata_id=868 (accessed 12 September 2006).
23. Committee on Chinese Medicine and Pharmacy. Database of registered Chinese herbal medicines - current and withdrawn. http://www.nhi.gov.tw/ webdata/webdata.asp?menu=&menu_id=26&webdata_id=868 (accessed 01 February 2007).
24. Committee on Chinese Medicine and Pharmacy. List of 100 unified formulae. http://www.ccmp.gov.tw/information/ formula_type.asp?relno=549&level=C (accessed 15 February 2007).
25. Berry MJA, Linoff GS. Market basket analysis and association rules. Data Mining Techniques: For Marketing, Sales, and Customer Relationship Management (2nd edn). Wiley Publishing, Inc.: Indianapolis, 2004; 287-320.
26. Goldman P. Herbal medicines today and the roots of modern pharmacology. Ann Intern Med 2001; 135: 594-600.
27. Lee CH, Chou YJ, Chen LS, et al. Utilization of ambulatory Chinese medical services under the national health insurance in Taiwan. Taiwan J Public Health 2004; 23: 100-107 (in Chinese).
28. Molony D. Understanding oriental medicine: herbs and herbal treatment. The American Association of Oriental Medicine's Complete Guide to Chinese Herbal Medicine. Berkley Books: New York, 1998; 63-72.
29. Chen LC, Tsao YT, Yen KY, et al. A pilot study comparing the clinical effects of Jia-Wey Shiau-Yau San, a traditional Chinese herbal prescription, and a continuous combined hormone replacement therapy in postmenopausal women with climacteric symptoms. Maturitas 2003; 44: 55-62.
30. Hirata JD, Swiersz LM, Zell B, et al. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 1997; 68: 981-986.
31. Shan LJ. Shijinmo Duiyao. Ren Min Jun Yi Chu Ban She: Beijing, 1996 (in Chinese).
32. Lee KG, Jin Kui Yao Lue. Zhi Yin: Taipei, 1990 (in Chinese).
33. Abraham J, Davis C. A comparative analysis of drug safety withdrawals in the UK and the US (1971-1992): implications for current regulatory thinking and policy. Soc Sci Med 2005; 61: 881-892. DOI: 10.1016/j.socscimed.2005.01.004
34. Deng JS. Quality Evaluation of Fang-Ji and Analysis of Marker Constituents. China Medical University: Taichung, 2002 (in Chinese).
35. Hsu YH, Tseng HH, Wen KC. Determination of aristolochic acid in fangchi radix. Ann Rept NLFD Taiwan ROC 1997; 15: 136-142 (in Chinese).
36. Tung CF, Ho YL, Tsai HY, et al. Studies on the commonly misused and adulterated Chinese crude drug species in Taiwan. Chin Med Coll J 1999; 8: 35-46 (in Chinese).
37. Jong TT, Lee MR, Hsiao SS, et al. Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/atmospheric pressure chemical ionization/tandem mass spectrometry. J Pharm Biomed Anal 2003; 33: 831-837. DOI: 10.1016/S0731-7085(03)00310-8
38. Committee on Chinese Medicine and Pharmacy. Regulations on aristolochic acid-contained Chinese herbal medicine products. http://www.ccmp.gov.tw/ public/public.asp?selno=561&relno=561&level=C (accessed 15 September 2006).